Stockreport

India's Zydus, Lupin sign deal to co-market Semaglutide injections [Yahoo! Finance]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF Semaglutide is a GLP-1 ?receptor agonist used to treat Type 2 Diabetes and, increasingly, for weight management by helping regulate blood sugar and appetite. The upco [Read more]